http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-057975-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate | 2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a6a3cec9cbacb82e8aff83ee373fc9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_777ddbb5fae24e6edef995ed66ff4c95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81cb38f672b3b055faac1ece22d0d693 |
| publicationDate | 2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-057975-A1 |
| titleOfInvention | DERIVATIVES OF QUINAZOLINS, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS. |
| abstract | Processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or clinical disorders mediated by cytokines. Claim 1: A compound characterized in that it responds to Formula (1), wherein m is 0, 1 or 2; R1 is halogen, hydroxy, cyano, trifluoromethyl, trifluoromethoxy, C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkoxy, C2-6 alkenyl, C2-6 alkynyl, C2-6 alkanoyl, C1-6 alkylthiol, C1- alkylsulfinyl 6, C 1-6 alkylsulfonyl, C 2-6 hydroxyalkoxy, C 2-6 amino-alkoxy, C 2-6 cyanoalkoxy, C 1-6 alkylamino-C 2-6 alkoxy, di- [C 1-6 alkyl] amino C 2-6 alkoxy , C1-6 alkoxy-C2-6 alkoxy, carbamyl C1-6 alkoxy, N-C1-6carbamyl-C1-6 alkoxy, amino- C1-6 alkyl, C1-6 alkylamino-C1-6 alkyl, di [alkyl C1-6] amino-C1-6 alkyl, carbamyl-C1-6 alkyl, N-alkylcarbamyl C1-6-C1-6 alkyl, hydroxy-C2-6 alkylamino, cyano-C2-6 alkylamino, C2-6 halogen-alkylamino , C2-6 aminoalkylamino, C1-6 alkoxy-C2-6 alkylamino, C1-6 alkylaminoC2-6 alkylamino, di- [C1-6 alkyl] aminoC2-6 alkylamino, heteroaryl, C1-6 heteroarylalkyl, heteroaryloxy, heteroaryl-C 1-6 alkoxy, heteroarylamino, heterocyclyl, heterocyclyl-C 1-6 alkyl, heterocyclyloxy, heterocyclyl-C 1-6 alkoxy and heterocyclyl no, and wherein any aryl, heteroaryl or heterocyclyl group in an R1 substituent may optionally have 1 or 2 substituents selected from hydroxyl, halogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl C 1-6, C 3-6 cycloalkyl-C 1-6 alkoxy, C 1-6 alkoxy, carboxyl, C 1-6 alkoxycarbonyl, C 1-6 alkoxycarbonyl-C 1-6 alkyl, N-C 1-6 alkylcarbamyl, N, N-di- [ C1-6 alkyl] carbamyl, C2-6 alkanoyl, amino, C1-6 alkylamino, di- [C1-6 alkyl] amino, halogen-C1-6 alkyl, hydroxy-C1-6 alkyl, C1-6 alkoxy-C1 alkyl -6, cyano-C 1-6 alkyl, carboxy-C 1-6 alkyl, amino C 1-6 alkyl, C 1-6 alkylamino-C 1-6 alkyl and di- [C 1-6 alkyl] amino-alkyl, and wherein any of the R1 substituents that have been defined comprising a CH2 group that is attached to 2 carbon atoms or a CH3 group that is attached to a carbon or nitrogen atom may optionally have in each of said CH2 or CH3 groups one or more substituents selected from halogen or, hydroxyl, amino, trifluoromethyl, trifluoromethoxy, oxo, carboxyl, carbamyl, acetamido, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkoxy, C 1-6 alkoxy, C 1-6 alkylamino -6, di- [C1-6 alkyl] amino, hydroxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, halogen-C1-6 alkyl, C1-6 alkoxy-C2-6 alkoxy, C1- alkoxycarbonyl 6, carbamyl, N-C1-6 alkylcarbamyl, N, N-di- [C1-6 alkyl] carbamyl, C1-6 sulfonyl, C1-6 sulfamyl, heteroaryl, heteroaryl-C1-6 alkyl, heterocyclyl and heterocyclyloxy, and in wherein any heterocyclyl group in an R1 substituent may optionally have 1 or 2 oxo or thioxo substituents; R2 is halogen, trifluoromethyl or C1-6 alkyl; R3 is hydrogen, halogen or C1-6 alkyl; and R4 is hydroxy, C1-6 alkyl or C1-6 alkoxy and any carbon atom included in R4 may be optionally substituted by one or more halogen; or a salt thereof acceptable for pharmaceutical use. |
| priorityDate | 2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.